MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Clinical trials for MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS trials appear
Sign up with your email to follow new studies for MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to sharpen diagnosis of rare brain disease
Diagnosis Recruiting nowThis study looks at two different lab tests (live-cell and fixed-cell) to see which one is better at diagnosing MOGAD, a rare autoimmune disease that affects the brain and nerves. Researchers will test 240 adults who are suspected of having MOGAD, along with people who have other…
Matched conditions: MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Sponsor: Huashan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New registry to track pregnancy and MS: what happens to mothers and babies?
Knowledge-focused Recruiting nowThis registry follows 1,500 women with multiple sclerosis (MS) or related conditions through pregnancy and after childbirth. Researchers will track relapses, use of disease-modifying drugs, and outcomes for both mothers and children. The goal is to better understand how MS and it…
Matched conditions: MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG)-ANTIBODY RELATED DISORDERS
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC